Novel Liver-Targeting Drug Offers Hope for AAT Deficiency

The investigational drug fazirsiran improved important liver parameters associated with alpha-1-antitrypsin deficiency.
Medscape Medical News

source https://www.medscape.com/viewarticle/976287?src=rss